# Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

> **NCT06520319** · PHASE1 · RECRUITING · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Medullary Thyroid Carcinoma

## Interventions

- **DRUG:** 68Ga-MGS5

## Key facts

- **NCT ID:** NCT06520319
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-21
- **Primary completion:** 2024-12
- **Final completion:** 2025-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520319, "Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06520319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*